Agoriwo MW, Joseph C, Franzén E, Unger M (2024) Assessing the factors that influence the utilization and delivery of rehabilitation services among persons with parkinson’s disease: a scoping review. J Eval Clin Pract 30(6):873–886. https://doi.org/10.1111/jep.13999

Article  PubMed  Google Scholar 

Ahmad OE, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M (2000) Age standardization of rates: a new WHO standard GPE discussion paper series. World Health Organization, Geneva

Google Scholar 

Atterling Brolin K, Schaeffer E, Kuri A, Rumrich IK, Schumacher Schuh AF, Darweesh SKL, Kaasinen V, Tolppanen AM, Chahine LM, Noyce AJ (2025) Environmental risk factors for parkinson’s disease: a critical review and policy implications. Mov Disord 40(2):204–221. https://doi.org/10.1002/mds.30067

Article  PubMed  Google Scholar 

Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of parkinson’s disease. Lancet 403(10423):283–292. https://doi.org/10.1016/S0140-6736(23)01419-8

Article  PubMed  PubMed Central  Google Scholar 

Bianchi VE, Rizzi L, Somaa F (2023) The role of nutrition on parkinson’s disease: a systematic review. Nutr Neurosci 26(7):605–628. https://doi.org/10.1080/1028415X.2022.2073107

Article  CAS  PubMed  Google Scholar 

Bugiani O (2020) The puzzle of preserved cognition in the oldest old. Neurol Sci 41(2):441–447. https://doi.org/10.1007/s10072-019-04111-y

Article  PubMed  Google Scholar 

Central Bureau of Statistics (2025) Last Updated December. http://www.cbs.gov.il/en/mediarelease/Pages/2024/Population-of-Israel-on-the-Eve-of-2025.aspx. Accessed 22 Feb 2024

Chen H (2016) Are we ready for a potential increase in Parkinson incidence?? JAMA Neurol 73(8):919–921. https://doi.org/10.1001/jamaneurol.2016.1599

Article  PubMed  Google Scholar 

Chillag-Talmor O, Giladi N, Linn S, Gurevich T, El-Ad B, Silverman B, Friedman N, Peretz C (2011) Use of a refined drug tracer algorithm to estimate prevalence and incidence of parkinson’s disease in a large Israeli population. J Parkinsons Dis 1(1):35–47. https://doi.org/10.3233/JPD-2011-11024

Article  PubMed  Google Scholar 

Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK (2009) Estimating average annual per cent change in trend analysis. Stat Med 28(29):3670–3682

PubMed  PubMed Central  Google Scholar 

Costa HE, Cairrao E (2024) Effect of bisphenol A on the neurological system: a review update. Arch Toxicol 98(1):1–73. https://doi.org/10.1007/s00204-023-03614-0

Article  CAS  PubMed  Google Scholar 

Dammertz L, Schrag A, Bohlken J, Heuer J, Kohring C, Schorlemmer J, Akmatov MK, Bätzing J, Holstiege J (2023) Falling incidence of parkinson’s disease in Germany. Eur J Neurol 30(10):3124–3131. https://doi.org/10.1111/ene.16000

Article  PubMed  Google Scholar 

Darweesh SK, Koudstaal PJ, Stricker BH, Hofman A, Ikram MA (2016) Trends in the incidence of Parkinson disease in the general population: the Rotterdam study. Am J Epidemiol 183(11):1018–1026. https://doi.org/10.1093/aje/kwv271

Article  PubMed  Google Scholar 

Denouel A, Brandel JP, Seilhean D, Laplanche JL, Elbaz A, Haik S (2023) The role of environmental factors on sporadic Creutzfeldt-Jakob disease mortality: evidence from an age-period-cohort analysis. Eur J Epidemiol 38(7):757–764. https://doi.org/10.1007/s10654-023-01004-5

Article  PubMed  PubMed Central  Google Scholar 

Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 83–8. https://doi.org/10.3233/JPD-181474

Article  PubMed  PubMed Central  Google Scholar 

Emre M, Ford PJ, Bilgiç B, Uç EY (2014) Cognitive impairment and dementia in parkinson’s disease: practical issues and management. Mov Disord 9(5):663–672. https://doi.org/10.1002/mds.25870

Article  Google Scholar 

Fahn S, Elton R, Members of the UPDRS Development Committee (1987) The unified parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in parkinson’s disease, vol 2. McMellam Health Care Information, Florham Park, pp 153–163

Google Scholar 

Gibb WR, Lees AJ (1988) The relevance of the lewy body to the pathogenesis of idiopathic parkinson’s disease. J Neurol Neurosurg Psychiatr 51:745–752. https://doi.org/10.1136/jnnp.51.6.745

Article  CAS  Google Scholar 

Gowers WR (1892) A Manual of Diseases of the Nervous System, 2nd edn. J & A Churchill, London, p 636

Google Scholar 

Han S, Kim S, Kim H, Shin HW, Na KS, Suh HS (2019) Prevalence and incidence of parkinson’s disease and drug-induced parkinsonism in Korea. BMC Public Health 19(1):1328. https://doi.org/10.1186/s12889-019-7664-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harding Z, Wilkinson T, Stevenson A, Horrocks S, Ly A, Schnier C, Breen DP, Rannikmäe K, Sudlow CLM (2019) Identifying parkinson’s disease and parkinsonism cases using routinely collected healthcare data: a systematic review. PLoS ONE 14(1):e0198736. https://doi.org/10.1371/journal.pone.0198736

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hatcher-Martin JM, Gearing M, Steenland K, Levey AI, Miller GW, Pennell KD (2012) Association between polychlorinated biphenyls and parkinson’s disease neuropathology. Neurotoxicology 33(5):1298–1304. https://doi.org/10.1016/j.neuro.2012.08.002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology. Neurology 17(5):427–442. https://doi.org/10.1212/WNL.17.5.427

Article  CAS  PubMed  Google Scholar 

Hornykiewicz O (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18(2):925–964

CAS  PubMed  Google Scholar 

Jellinger KA (2003) Alpha-synuclein pathology in parkinson’s and alzheimer’s disease brain: incidence and topographic distribution–a pilot study. Acta Neuropathol 106(3):191–201. https://doi.org/10.1007/s00401-003-0725-y

Article  PubMed  Google Scholar 

Kesidou E, Theotokis P, Damianidou O, Boziki M, Konstantinidou N, Taloumtzis C, Sintila SA, Grigoriadis P, Evangelopoulos ME, Bakirtzis C, Simeonidou C (2023) CNS ageing in health and neurodegenerative disorders. J Clin Med 12(6):2255. https://doi.org/10.3390/jcm12062255

Article  PubMed  PubMed Central  Google Scholar 

Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351

CAS  PubMed  Google Scholar 

Kimura H, Kurimura M, Wada M, Kawanami T, Kurita K, Suzuki Y, Katagiri T, Daimon M, Kayama T, Kato T (2002) Female preponderance of parkinson’s disease in Japan. Neuroepidemiology 21(6):292–296. https://doi.org/10.1159/000065527

Article  CAS  PubMed  Google Scholar 

Kinsella KG (2005) Future longevity-demographic concerns and consequences. J Am Geriatr Soc 53(9 Suppl):S299-303. https://doi.org/10.1111/j.1532-5415.2005.53494.x

Article  PubMed  Google Scholar 

Korczyn AD (2024) Rethinking parkinson’s disease: a syndromic perspective. Mov Disord 39(6):1079–1080. https://doi.org/10.1002/mds.29833

Article  PubMed  Google Scholar 

Kouli A, Williams-Gray CH (2022) Age-Related adaptive immune changes in parkinson’s disease. J Parkinsons Dis12(s1):S93–S104. https://doi.org/10.3233/JPD-223228

Article  CAS  Google Scholar 

Liu WM, Wu RM, Lin JW, Liu YC, Chang CH, Lin CH (2016) Time trends in the prevalence and incidence of parkinson’s disease in taiwan: a nationwide, population-based study. J Formos Med Assoc 115(7):531–538. https://doi.org/10.1016/j.jfma.2015.05.014

Article  PubMed  Google Scholar 

Luo Y, Qiao L, Li M, Wen X, Zhang W, Li X (2025) Global, regional, National epidemiology and trends of parkinson’s disease from 1990 to 2021: findings from the global burden of disease study 2021. Front Aging Neurosci 16:1498756. https://doi.org/10.3389/fnagi.2024.1498756

Article  PubMed  PubMed Central